|
Mindfulness-Based Art Therapy for Cancer Patients Clinical Trials Info presented on Clinical Trials Search is not intended to be a substitute for certified medical advice, visits or professional assistance using a real physician. We are not physicians. Always consult your dr. about Mindfulness-Based Art Therapy for Cancer Patients conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Mindfulness-Based Art Therapy for Cancer Patients Clinical research trials and Mindfulness-Based Art Therapy for Cancer Patients health trials happen in many of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new drugs. The function of the studies / projects is to resolve particular human medical questions. Clinical trials are a popular manner for mDs, government agencies, and private sector corporations to discover remedies for all varieties of circumstances, like Mindfulness-Based Art Therapy for Cancer Patients. Mindfulness-Based Art Therapy for Cancer Patients Clinical Trials and other clinical trials allow volunteers to obtain healthcare treatment options before they are available to the masses. Some times the participants undergo professional assistance for free of charge, and occasionally they are paid for their time. Sometimes there is a cost for a Mindfulness-Based Art Therapy for Cancer Patients clinical trial. Human subjects often get the best healthcare available for their Mindfulness-Based Art Therapy for Cancer Patients condition. Dangers are a reality, however, and may include additional or frequent mD visits, healthcare dangers (potentially life-jeopardising), and/or the treatment being ineffectual. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "M" Clinical Trials Conditions > Mindfulness-Based Art Therapy for Cancer Patients  Mindfulness-Based Art Therapy for Cancer Patients
Mindfulness-Based Art Therapy for Cancer Patients
For Condition: Cancer
Status: No longer recruiting
Sponsor(s): National Center for Complementary and Alternative Medicine (NCCAM) ,
Synopsis: The purpose of this study is to determine whether cancer patients who receive the mindfulness-based art therapy (MBAT) program demonstrate improvement in health-related quality of life, a reduction in stress-related symptoms, and enhanced coping responses.
Details: Psychosocial interventions, especially supportive-expressive group therapies, have been associated with significant improvements in health status, quality of life and coping behaviors, in patients with cancer. The purpose of the proposed pilot research study is to investigate a newly developed group therapy for cancer patients, MBAT. This proposed, randomized, controlled study follows a successful preliminary investigation of MBAT conducted at Thomas Jefferson University Hospital. MBAT integrates known benefits of art therapy, group therapy, and mindfulness-based stress reduction. Each of these fundamentally different modalities has documented usefulness in the treatment of cancer patients. The multi-modal approach is designed to enhance both the supportive and expressive aspects of the group experience. The study will be done with 96 patients who have a variety of cancer types. Participants will be matched for age and assigned randomly to either the MBAT experimental group or a non-intervention control group. Both groups will continue to receive their usual oncologic/medical care. The MBAT program consists of eight weekly meetings of two and one half-hours in length. At the end of the eight weeks, participants in the control group will be crossed over to the experimental intervention arm for an additional eight weeks. Participants will be assessed pre- and post-intervention on measures of health-related quality of life, psychological distress, and coping, using standardized outcome instruments (SF-36, SCL-90-R and COPE). Our long-term goal is to collect sufficient data to determine the overall efficacy of this promising intervention and to identify which patients are particularly likely to benefit from MBAT.
Eligibility:
Study Type: Interventional, Educational/Counseling/Training, Randomized, Open Label, Factorial Assignment, Efficacy Study
Minimum Age/Maximum Age: 21 Years/
Genders: Both
Protocol Entry Criteria: Inclusion: - Diagnosis of cancer or cancer recurrence within the past 2 years. - Able to tolerate 8 weekly groups, 2 1/2 hours in length Exclusion: - Less than 4 months from original or recurrent diagnosis or beyond 2 years - Physically unable to attend groups - Non-stabilized major mental disorder - Children - Comprehension of written and spoken English at a level of less than 4th grade.
Total Enrollment: 114
Location and Contact Information:
Overall Study Official:
DanielMonti, Principal Investigator, Thomas Jefferson University
Thomas Jefferson University Hospital/Kimmel Cancer Center
Philadelphia, Pennsylvania, 19107
United States
Additional Information:
Study ID Numbers: 1 R21 AT00683-01;
Study Start Date: April 2002
Record last reviewed: October 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00034970
Other Cancer Studies:
1. Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
2. Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
3. UCN-01 and Irinotecan in Treating Patients With Metastatic or Unresectable Solid Tumors
4. Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients
5. Study of Irinotecan in Children.
Related Studies:
Other Cancer Clinical Trials
Other Pennsylvania Clinical Trials
Other Philadelphia Clinical Trials
Mindfulness-Based Art Therapy for Cancer Patients
|
|
|
|
|
|
|
|
